Evidence-based Pharmacogenomics: The Case of Statin-induced Myopathy

Evidence-based Pharmacogenomics: The Case of Statin-induced Myopathy

SLCO1B1 polymorphisms and statin-induced myopathy 
Stewart A. PLoS Evidence on Genomic Tests, Dec 4

The Clinical Pharmacogenomics Implementation Consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy. 
RA Wilke et al. Clin Pharma Thera 2012

Check out the PLoS Currents collection on Evidence on Genomic Tests

Check out guidelines and recommendations from the Clinical Pharmacogenomics Implementation Consortium

Check out methods and approaches of the EGAPP working group